These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 38669836)
81. Pharmacological management of narcolepsy with and without cataplexy. Kallweit U; Bassetti CL Expert Opin Pharmacother; 2017 Jun; 18(8):809-817. PubMed ID: 28443381 [TBL] [Abstract][Full Text] [Related]
82. Correlation between the Epworth Sleepiness Scale and the Maintenance of Wakefulness Test in patients with narcolepsy participating in two clinical trials of sodium oxybate. Erman M; Emsellem H; Black J; Mori F; Mayer G Sleep Med; 2017 Oct; 38():92-95. PubMed ID: 29031763 [TBL] [Abstract][Full Text] [Related]
83. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy. Harsh JR; Hayduk R; Rosenberg R; Wesnes KA; Walsh JK; Arora S; Niebler GE; Roth T Curr Med Res Opin; 2006 Apr; 22(4):761-74. PubMed ID: 16684437 [TBL] [Abstract][Full Text] [Related]
84. Relative efficacy of drugs for the treatment of sleepiness in narcolepsy. Mitler MM; Hajdukovic R Sleep; 1991 Jun; 14(3):218-20. PubMed ID: 1680245 [TBL] [Abstract][Full Text] [Related]
85. Modafinil reverses hypoexcitability of the motor cortex in narcoleptic patients: a TMS study. Nardone R; Bergmann J; Lochner P; Caleri F; Kunz A; Staffen W; Tezzon F; Ladurner G; Trinka E; Golaszewski S Sleep Med; 2010 Oct; 11(9):870-5. PubMed ID: 20810311 [TBL] [Abstract][Full Text] [Related]
86. Treatment of narcolepsy and other hypersomnias of central origin. Wise MS; Arand DL; Auger RR; Brooks SN; Watson NF; Sleep; 2007 Dec; 30(12):1712-27. PubMed ID: 18246981 [TBL] [Abstract][Full Text] [Related]
87. [Effect of modafinil in narcoleptic patients. Electrophysiologic and psychometric studies]. Laffont F; Agar N; Mayer G; Minz M Neurophysiol Clin; 1995; 25(2):84-95. PubMed ID: 7603416 [TBL] [Abstract][Full Text] [Related]
88. Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study. Inoue Y; Tabata T; Tsukimori N Sleep Med; 2021 Apr; 80():315-321. PubMed ID: 33631500 [TBL] [Abstract][Full Text] [Related]
89. Normalizing effects of modafinil on sleep in chronic cocaine users. Morgan PT; Pace-Schott E; Pittman B; Stickgold R; Malison RT Am J Psychiatry; 2010 Mar; 167(3):331-40. PubMed ID: 20080983 [TBL] [Abstract][Full Text] [Related]
90. The effect of modafinil on cortical excitability in patients with narcolepsy: a randomized, placebo-controlled, crossover study. Joo EY; Hong SB; Kim HJ; Lim YH; Koo DL; Ji KH; Tae WS Sleep Med; 2010 Oct; 11(9):862-9. PubMed ID: 20810312 [TBL] [Abstract][Full Text] [Related]
91. Narcolepsy, idiopathic hypersomnolence and related conditions. Quinnell TG; Smith IE Clin Med (Lond); 2011 Jun; 11(3):282-6. PubMed ID: 21902087 [No Abstract] [Full Text] [Related]
92. Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study. Ruoff C; Swick TJ; Doekel R; Emsellem HA; Feldman NT; Rosenberg R; Bream G; Khayrallah MA; Lu Y; Black J Sleep; 2016 Jul; 39(7):1379-87. PubMed ID: 27166238 [TBL] [Abstract][Full Text] [Related]
93. Armodafinil: a new treatment for excessive sleepiness. Lankford DA Expert Opin Investig Drugs; 2008 Apr; 17(4):565-73. PubMed ID: 18363520 [TBL] [Abstract][Full Text] [Related]
94. Psychological health in central hypersomnias: the French Harmony study. Dauvilliers Y; Paquereau J; Bastuji H; Drouot X; Weil JS; Viot-Blanc V J Neurol Neurosurg Psychiatry; 2009 Jun; 80(6):636-41. PubMed ID: 19211597 [TBL] [Abstract][Full Text] [Related]
95. Modafinil : a review of its use in excessive sleepiness associated with obstructive sleep apnoea/hypopnoea syndrome and shift work sleep disorder. Keating GM; Raffin MJ CNS Drugs; 2005; 19(9):785-803. PubMed ID: 16142993 [TBL] [Abstract][Full Text] [Related]
96. The unfinished journey with modafinil and discovery of a novel population of modafinil-immunoreactive neurons. Lin JS; Roussel B; Gaspar A; Zhao Y; Hou Y; Schmidt M; Jouvet A; Jouvet M Sleep Med; 2018 Sep; 49():40-52. PubMed ID: 30172629 [TBL] [Abstract][Full Text] [Related]
97. Effects of paraxanthine and caffeine on sleep, locomotor activity, and body temperature in orexin/ataxin-3 transgenic narcoleptic mice. Okuro M; Fujiki N; Kotorii N; Ishimaru Y; Sokoloff P; Nishino S Sleep; 2010 Jul; 33(7):930-42. PubMed ID: 20614853 [TBL] [Abstract][Full Text] [Related]
98. Dopaminergic-adrenergic interactions in the wake promoting mechanism of modafinil. Wisor JP; Eriksson KS Neuroscience; 2005; 132(4):1027-34. PubMed ID: 15857707 [TBL] [Abstract][Full Text] [Related]
99. Modafinil for narcolepsy: systematic review and meta-analysis. Golicki D; Bala MM; Niewada M; Wierzbicka A Med Sci Monit; 2010 Aug; 16(8):RA177-86. PubMed ID: 20671626 [TBL] [Abstract][Full Text] [Related]
100. Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil. Bastuji H; Jouvet M Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(5):695-700. PubMed ID: 2906157 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]